Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 305

1.

Liraglutide increases FGF-21 activity and insulin sensitivity in high fat diet and adiponectin knockdown induced insulin resistance.

Yang M, Zhang L, Wang C, Liu H, Boden G, Yang G, Li L.

PLoS One. 2012;7(11):e48392. doi: 10.1371/journal.pone.0048392. Epub 2012 Nov 12.

2.

Long-term high-fat diet links the regulation of the insulin-sensitizing fibroblast growth factor-21 and visfatin.

Sun B, Yang G, Yang M, Liu H, Boden G, Li L.

Cytokine. 2012 Jul;59(1):131-7. doi: 10.1016/j.cyto.2012.03.030. Epub 2012 Apr 27.

PMID:
22542568
3.

Liraglutide prevents hypoadiponectinemia-induced insulin resistance and alterations of gene expression involved in glucose and lipid metabolism.

Li L, Miao Z, Liu R, Yang M, Liu H, Yang G.

Mol Med. 2011;17(11-12):1168-78. doi: 10.2119/molmed.2011.00051. Epub 2011 Jul 11.

4.

[Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].

Zhao XY, Zhang LL, Suolang QZ, Yang GY, Li L, Li SB, Chen WW.

Zhonghua Gan Zang Bing Za Zhi. 2014 Nov;22(11):849-53. doi: 10.3760/cma.j.issn.1007-3418.2014.11.010. Chinese.

PMID:
25531383
5.

GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK.

Zhang L, Yang M, Ren H, Hu H, Boden G, Li L, Yang G.

Liver Int. 2013 May;33(5):794-804. doi: 10.1111/liv.12120. Epub 2013 Feb 24.

PMID:
23432843
6.

Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance.

Bartelt A, Orlando P, Mele C, Ligresti A, Toedter K, Scheja L, Heeren J, Di Marzo V.

Diabetologia. 2011 Nov;54(11):2900-10. doi: 10.1007/s00125-011-2274-6. Epub 2011 Aug 17.

PMID:
21847582
7.

Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice.

Lee YS, Cha BY, Choi SS, Choi BK, Yonezawa T, Teruya T, Nagai K, Woo JT.

J Nutr Biochem. 2013 Jan;24(1):156-62. doi: 10.1016/j.jnutbio.2012.03.014. Epub 2012 Aug 13.

PMID:
22898571
8.

Response to a long-term high-fat diet in the signature of genes involved in lipid metabolism in ApoE(-/-) mice.

Yang M, Li S, Liu H, Yang G, Li L.

Am J Med Sci. 2013 Sep;346(3):211-5. doi: 10.1097/MAJ.0b013e3182688026.

PMID:
23138120
10.

Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice.

Ellenbroek JH, Töns HA, Westerouen van Meeteren MJ, de Graaf N, Hanegraaf MA, Rabelink TJ, Carlotti F, de Koning EJ.

Diabetologia. 2013 Sep;56(9):1980-6. doi: 10.1007/s00125-013-2957-2. Epub 2013 Jun 16.

PMID:
23771206
11.

Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.

Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.

Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1.

12.

Liraglutide enhances insulin sensitivity by activating AMP-activated protein kinase in male Wistar rats.

Yamazaki S, Satoh H, Watanabe T.

Endocrinology. 2014 Sep;155(9):3288-301. doi: 10.1210/en.2013-2157. Epub 2014 Jun 20.

PMID:
24949659
13.

Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet.

Mells JE, Fu PP, Sharma S, Olson D, Cheng L, Handy JA, Saxena NK, Sorescu D, Anania FA.

Am J Physiol Gastrointest Liver Physiol. 2012 Jan 15;302(2):G225-35. doi: 10.1152/ajpgi.00274.2011. Epub 2011 Oct 28.

14.

Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice.

Chen LN, Lyu J, Yang XF, Ji WJ, Yuan BX, Chen MX, Ma X, Wang B.

Int J Mol Med. 2013 Oct;32(4):892-900. doi: 10.3892/ijmm.2013.1453. Epub 2013 Jul 19.

PMID:
23877319
15.

Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).

Nygaard EB, Møller CL, Kievit P, Grove KL, Andersen B.

Int J Obes (Lond). 2014 Feb;38(2):183-91. doi: 10.1038/ijo.2013.79. Epub 2013 May 21.

17.

Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.

Wiedemann MS, Wueest S, Item F, Schoenle EJ, Konrad D.

Am J Physiol Endocrinol Metab. 2013 Aug 1;305(3):E388-95. doi: 10.1152/ajpendo.00179.2013. Epub 2013 Jun 4.

18.

Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels.

Haluzik MM, Lacinova Z, Dolinkova M, Haluzikova D, Housa D, Horinek A, Vernerova Z, Kumstyrova T, Haluzik M.

Endocrinology. 2006 Sep;147(9):4517-24. Epub 2006 Jun 1.

PMID:
16740970
19.

High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations.

de Oliveira C, de Mattos AB, Biz C, Oyama LM, Ribeiro EB, do Nascimento CM.

Lipids Health Dis. 2011 Jan 18;10:11. doi: 10.1186/1476-511X-10-11.

20.

A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity.

Noyan-Ashraf MH, Shikatani EA, Schuiki I, Mukovozov I, Wu J, Li RK, Volchuk A, Robinson LA, Billia F, Drucker DJ, Husain M.

Circulation. 2013 Jan 1;127(1):74-85. doi: 10.1161/CIRCULATIONAHA.112.091215. Epub 2012 Nov 27.

Supplemental Content

Support Center